Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company's only segment is providing Research and Development services. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API) Speciality chemicals, and formulated drugs under contract research and manufacturing services. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, , Hyderabad, TG, 500
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Suven Life Sciences Ltd or scroll over to Suven Life Sciences Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Suven Life Sciences Ltd?
The share price of Suven Life Sciences Ltd stocks is ₹101.85 as on 01/03/2024
What is the Market Cap of Suven Life Sciences Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Suven Life Sciences Ltd stock is ₹2,221.1 Cr on 01/03/2024.
In which sector / industry does Suven Life Sciences Ltd operate?
Suven Life Sciences Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Suven Life Sciences Ltd?
The revenue of Suven Life Sciences Ltd as of 2022 was ₹13.5 Cr
What is the PE ratio of Suven Life Sciences Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Suven Life Sciences Ltd is
-21.35 as on 01/03/2024.
What is the 52 week high price of Suven Life Sciences Ltd?
The 52 week high of Suven Life Sciences Ltd stock is ₹128.79.
What is the 52 week low price of Suven Life Sciences Ltd?
The 52 week low of Suven Life Sciences Ltd stock is ₹45.01.
Can fractional shares of Suven Life Sciences Ltd be purchased?
No, you cannot buy fractional shares of Suven Life Sciences Ltd, or any listed Indian company as of now.